Study Shows COVID-19 Risk Might be Linked to Blood Type
June 10, 2020| |
Researchers from the University of Copenhagen and other partner institutions reported that two human gene variants could make people more prone to lung failure due to COVID-19. The preprint article about the study is published in MedRxiv.
The genome-wide association analysis included 1,980 patients with COVID-19 respiratory failure at seven centers in the Italian and Spanish epicenters of the SARS-CoV-2 pandemic in Europe (Milan, Monza, Madrid, San Sebastian, and Barcelona). Results showed that one variant lies in the overlay of the genome that controls blood groupings. People with blood type A+ are much prone to lung failure compared with those with other blood types, while those with type O blood were less prone. On the other hand, the second variant which is located in chromosome 3 and close to 6 genes, includes one that is linked with the molecular receptor that the virus utilizes to penetrate human cells.
Read more information from Nature and MedRxiv.| |
You might also like:
- Scientists Say COVID-19 Coronavirus Has Natural Origins
- Pocket K No. 58: COVID-19 Treatment Efforts Using Plant Technologies
- First Results from Human COVID-19 Immunology Study Identify Universally Effective Antibodies
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
News from Around the World
- Study Highlights The Role of Communication in Novel Food Acceptance
- COVID-19 Driving Up Hunger in Food Crisis Hotspots, Urgent Action Necessary
- Top 5 Biotech Crops Occupy 99% of Global Biotech Crop Area
- Experts Urge States to Embrace Genome Editing in Addressing Key Challenges in Health and Agriculture
- International Research Team Document First Use of Maize in Mesoamerica
- Farmers in Paraguay Achieve Yield Increases through Agri-biotech
-
Plant
- USDA Classifies Gene-Edited Soybean As Non-Regulated
- Experts Use Viruses for Transgene-free Gene Editing in Plants
-
Health
- CRISPR Technique 90% Effective in Reducing SARS-CoV-2 Coronavirus
- Study Shows COVID-19 Risk Might be Linked to Blood Type
-
Read the latest: - Biotech Updates (April 17, 2024)
- Gene Editing Supplement (April 10, 2024)
- Gene Drive Supplement (February 22, 2023)
-
Subscribe to BU: - Share
- Tweet